Thermo Fisher Scientific Shares Rise Following Q3 2026 Earnings Beat
Thermo Fisher Scientific (TMO) saw its stock price rise in premarket trading following the release of third-quarter 2026 financial results that exceeded analyst expectations. The company's strong performance was primarily driven by robust growth within its Laboratory Products and Biopharma Services divisions. The Waltham, Massachusetts-based life sciences leader reported significant revenue contributions from these key units, bolstering its overall quarterly financials. This earnings beat reflects resilient demand in the healthcare and biopharmaceutical sectors despite broader market fluctuations.
Tickers: $TMO
Topics: biopharma services earnings report life sciences revenue growth
Read the full article at Seeking Alpha
Part of the story SpaceX Shares Surge Following Q3 Earnings Beat Driven by Super Intelligence Division (9 articles)